Blood Storage Device Market Size to Reach US$1.8 Billion by 2034 at 4.46% CAGR

Photo of author

Growing transfusion volumes and rising emphasis on blood safety are strengthening demand for reliable temperature-controlled storage solutions. Hospitals and blood banks are upgrading legacy refrigeration systems with energy-efficient, monitored, medical-grade equipment. Cold-chain modernization is also gaining importance across emerging healthcare systems and decentralized blood collection networks.

The Blood Storage Device Market is projected to grow from US$1.27 billion in 2025 to US$1.8 billion by 2034, registering a CAGR of 4.46% from 2026 to 2034. Growth is driven by increasing surgical, oncology, trauma, and maternity care volumes, alongside stringent requirements for temperature monitoring and blood product integrity. The industry is also shifting toward connected equipment, automated alarms, digital temperature records, and energy-efficient refrigeration technologies.

Get Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00022294

Rising Demand for Advanced Blood Storage Infrastructure

Blood storage equipment plays a critical role in maintaining the quality and safety of whole blood, red blood cells, plasma, and other blood components. Hospitals and blood banks increasingly require refrigerators and freezers that maintain precise temperature ranges while providing continuous monitoring and alarm capabilities.

Refrigerators represented the largest product segment, accounting for approximately 66% to 70% share in 2025. Their dominance is attributed to routine storage requirements for whole blood and red blood cells. Freezers remain essential for plasma and other components requiring frozen preservation. Replacement of aging equipment is also creating recurring demand as healthcare facilities prioritize uptime, energy efficiency, and compliance.

Hospitals and Blood Banks Drive Adoption

Hospitals represent a significant application base due to recurring transfusion requirements across emergency departments, surgical units, oncology centers, and maternity services. Modern healthcare facilities are increasingly standardizing refrigeration systems across multiple locations to simplify maintenance, validation, and temperature documentation.

Blood banks accounted for approximately 36% to 40% of the industry in 2025 and are expected to record a faster CAGR of 4.8% to 5.4% through 2034. Expansion of centralized blood collection and processing networks is increasing requirements for high-capacity refrigerators, plasma freezers, backup systems, and digitally traceable storage solutions.

Regional Growth and Emerging Opportunities

North America held approximately 34% to 36% share in 2025 and is projected to expand at a CAGR of 3.8% to 4.3% through 2034. The US represents the largest portion of regional demand, supported by mature transfusion infrastructure, hospital system standardization, accredited blood banks, and replacement of aging equipment.

Europe accounted for around 27% to 29% share in 2025. Germany, the UK, France, Italy, and Spain are key contributors, supported by stringent quality requirements and healthcare infrastructure modernization.

Asia Pacific is expected to be the fastest-growing major region, with a projected CAGR of 5.2% to 5.8%. China, Japan, India, South Korea, and Australia are investing in hospital expansion, blood bank modernization, emergency preparedness, and decentralized healthcare infrastructure.

Technology Trends and Competitive Landscape

Technological development is increasingly focused on maintaining stable temperatures while reducing energy consumption and improving operational visibility. Variable-speed compressors, natural refrigerants, improved insulation, automatic defrost systems, digital temperature recording, access controls, and remote alarm capabilities are becoming important purchasing criteria.

Key companies operating in the industry include:

  • Thermo Fisher Scientific Inc.
  • Blue Star Limited
  • Helmer Scientific Inc.
  • Vestfrost Solutions A/S
  • Philipp Kirsch GmbH
  • Zhongke Meiling Cryogenics Company Limited
  • LEC Medical
  • Qingdao Haier Biomedical Co., Ltd.
  • Abbott Diagnostics Inc.
  • Beckman Coulter, Inc.

Competition is shaped by refrigeration performance, temperature uniformity, energy efficiency, service capabilities, validation support, and digital monitoring. Manufacturers are increasingly differentiating through lifecycle services, connected monitoring platforms, and customized solutions for hospitals and blood banks.

Interested in Purchasing this Report? Click here @ https://www.theinsightpartners.com/buy/TIPRE00022294

 

Future Outlook

The Blood Storage Device Market is expected to maintain steady expansion through 2034 as healthcare providers prioritize blood safety, cold-chain resilience, and efficient inventory management. Connected monitoring and predictive maintenance are likely to become more prominent, enabling automated compliance documentation and early detection of equipment failures. Asia Pacific and other emerging regions offer significant opportunities as governments and healthcare organizations strengthen blood collection and storage infrastructure.

Related Report:

1) Benzodiazepine Drugs Market Size, Share & Demand by 2034

2) Critical Limb Ischemia Treatment Market Size, Trends & Growth by 2034

3) Periodontal Therapeutics Market Growth, Size, Share, Trends, Key Players and Forecast by 2034

About Us –

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Us:
Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in : Korean German Japanese French Chinese Italian Spanish

Leave a Comment